• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺结核后肺部疾病的发病机制:第二届国际肺结核后研讨会定义知识空白和研究重点。

Pathogenesis of Post-Tuberculosis Lung Disease: Defining Knowledge Gaps and Research Priorities at the Second International Post-Tuberculosis Symposium.

机构信息

Departments of Medicine, Epidemiology, and Global Health, Emory University School of Medicine and Rollins School of Public Health, Atlanta, Georgia.

Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts.

出版信息

Am J Respir Crit Care Med. 2024 Oct 15;210(8):979-993. doi: 10.1164/rccm.202402-0374SO.

DOI:10.1164/rccm.202402-0374SO
PMID:39141569
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11531093/
Abstract

Post-tuberculosis (post-TB) lung disease is increasingly recognized as a major contributor to the global burden of chronic lung disease, with recent estimates indicating that over half of TB survivors have impaired lung function after successful completion of TB treatment. However, the pathologic mechanisms that contribute to post-TB lung disease are not well understood, thus limiting the development of therapeutic interventions to improve long-term outcomes after TB. This report summarizes the work of the Pathogenesis and Risk Factors Committee for the Second International Post-Tuberculosis Symposium, which took place in Stellenbosch, South Africa, in April 2023. The committee first identified six areas with high translational potential: ) tissue matrix destruction, including the role of matrix metalloproteinase dysregulation and neutrophil activity; ) fibroblasts and profibrotic activity; ) granuloma fate and cell death pathways; ) mycobacterial factors, including pathogen burden; ) animal models; and ) the impact of key clinical risk factors, including HIV, diabetes, smoking, malnutrition, and alcohol. We share the key findings from a literature review of those areas, highlighting knowledge gaps and areas where further research is needed.

摘要

肺结核(post-TB)后肺部疾病日益被视为导致全球慢性肺部疾病负担的主要因素之一,最近的估计表明,在成功完成结核病治疗后,超过一半的结核病幸存者的肺功能受损。然而,导致肺结核后肺部疾病的病理机制尚不清楚,从而限制了治疗干预措施的发展,以改善结核病后的长期结局。本报告总结了于 2023 年 4 月在南非斯泰伦博斯举行的第二届国际肺结核后研讨会发病机制和危险因素委员会的工作。委员会首先确定了六个具有高转化潜力的领域:组织基质破坏,包括基质金属蛋白酶失调和中性粒细胞活性的作用;成纤维细胞和促纤维化活性;肉芽肿命运和细胞死亡途径;分枝杆菌因素,包括病原体负担;动物模型;以及关键临床危险因素的影响,包括艾滋病毒、糖尿病、吸烟、营养不良和酒精。我们分享了对这些领域的文献综述的主要发现,突出了知识差距和需要进一步研究的领域。

相似文献

1
Pathogenesis of Post-Tuberculosis Lung Disease: Defining Knowledge Gaps and Research Priorities at the Second International Post-Tuberculosis Symposium.肺结核后肺部疾病的发病机制:第二届国际肺结核后研讨会定义知识空白和研究重点。
Am J Respir Crit Care Med. 2024 Oct 15;210(8):979-993. doi: 10.1164/rccm.202402-0374SO.
2
Six-month therapy for abdominal tuberculosis.腹部结核的六个月治疗
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD012163. doi: 10.1002/14651858.CD012163.pub2.
3
Low-complexity manual nucleic acid amplification tests for pulmonary tuberculosis in children.用于儿童肺结核的低复杂度手动核酸扩增检测
Cochrane Database Syst Rev. 2025 Jun 25;6(6):CD015806. doi: 10.1002/14651858.CD015806.pub2.
4
Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications.针对患者及护理人员的干预措施,以提高对镰状细胞病的认识及其相关并发症的识别能力。
Cochrane Database Syst Rev. 2016 Oct 6;10(10):CD011175. doi: 10.1002/14651858.CD011175.pub2.
5
Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.用于检测HIV阳性成年人活动性结核病的侧向流动尿液脂阿拉伯甘露聚糖检测法
Cochrane Database Syst Rev. 2016 May 10;2016(5):CD011420. doi: 10.1002/14651858.CD011420.pub2.
6
Post tuberculosis chronic lung disease in tuberculosis HIV coinfected and non-HIV individuals in Sub-Saharan Africa: A systematic review and meta-analysis.撒哈拉以南非洲地区结核分枝杆菌/人类免疫缺陷病毒(HIV)合并感染和非合并感染人群的结核后慢性肺部疾病:系统评价和荟萃分析。
Int J Mycobacteriol. 2022 Apr-Jun;11(2):139-144. doi: 10.4103/ijmy.ijmy_66_22.
7
Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.用于肺外结核病和利福平耐药性的Xpert MTB/RIF检测
Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2.
8
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.快速分子检测结核分枝杆菌和结核分枝杆菌耐药性:受检者和提供者观点的定性证据综合评价。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD014877. doi: 10.1002/14651858.CD014877.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.尿液中脂阿拉伯甘露聚糖(LAM)的检测是撒哈拉以南非洲地区接受HIV相关结核病治疗患者死亡风险的独立预测指标:一项系统评价和荟萃分析。
BMC Med. 2016 Mar 23;14:53. doi: 10.1186/s12916-016-0603-9.

引用本文的文献

1
Increased vaccine efficacy against tuberculosis with a recombinant BCG overexpressing the STING agonist cyclic di-AMP.一种过表达STING激动剂环二腺苷酸的重组卡介苗增强了对结核病的疫苗效力。
bioRxiv. 2025 Jul 17:2025.07.17.665241. doi: 10.1101/2025.07.17.665241.
2
Pathophysiology, clinical manifestation, and treatment of tuberculosis-associated chronic obstructive pulmonary disease: a narrative review.结核相关慢性阻塞性肺疾病的病理生理学、临床表现及治疗:一项叙述性综述
Ewha Med J. 2025 Apr;48(2):e24. doi: 10.12771/emj.2025.00059. Epub 2025 Mar 19.
3
Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials.在结核病药物试验中纳入以患者为中心的非微生物学终点指标和生物标志物。
Front Antibiot. 2025 May 22;4:1570989. doi: 10.3389/frabi.2025.1570989. eCollection 2025.
4
Prevalence, Progression, and Treatment of Asymptomatic Tuberculosis: A Prospective Cohort Study in Lanxi County, Zhejiang Province, China.无症状结核病的患病率、进展及治疗:中国浙江省兰溪县的一项前瞻性队列研究
Open Forum Infect Dis. 2025 May 12;12(5):ofaf275. doi: 10.1093/ofid/ofaf275. eCollection 2025 May.
5
Post-tuberculosis Sequelae and the Burden of "Long TB": Continuing TB Care after Treatment Completion.肺结核后遗症与“长期结核病”负担:治疗结束后的持续结核病护理
Am J Respir Crit Care Med. 2025 Jun;211(6):912-913. doi: 10.1164/rccm.202502-0442ED.
6
The role of neutrophil response in lung damage and post-tuberculosis lung disease: a translational narrative review.中性粒细胞反应在肺损伤和肺结核后肺部疾病中的作用:一项转化性叙述性综述
Front Immunol. 2025 Mar 7;16:1528074. doi: 10.3389/fimmu.2025.1528074. eCollection 2025.
7
A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2025 Update for Clinicians and Scientists.结核病和非结核分枝杆菌病年度回顾:2025年临床医生和科学家最新进展
Pathog Immun. 2025 Mar 2;10(2):1-45. doi: 10.20411/pai.v10i2.791. eCollection 2025.

本文引用的文献

1
Perspectives from the 2 International Post-Tuberculosis Symposium: mobilising advocacy and research for improved outcomes.第二届国际结核病后研讨会的观点:动员宣传与研究以改善结局
IJTLD Open. 2024 Mar 1;1(3):111-123. doi: 10.5588/ijtldopen.23.0619. eCollection 2024 Mar.
2
Is Tobacco Use Associated With Risk of Recurrence and Mortality Among People With TB?: A Systematic Review and Meta-Analysis.吸烟与结核病患者的复发和死亡风险有关吗?一项系统评价和荟萃分析。
Chest. 2024 Jan;165(1):22-47. doi: 10.1016/j.chest.2023.08.021. Epub 2023 Aug 29.
3
Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India.成人肺结核患者的营养支持:在印度恰尔康得邦 RATIONS 试验中的一个方案性队列中的结局。
Lancet Glob Health. 2023 Sep;11(9):e1402-e1411. doi: 10.1016/S2214-109X(23)00324-8. Epub 2023 Aug 8.
4
Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial.在印度,对肺结核患者的家庭接触者进行营养补充以预防肺结核发病(RATIONS):一项基于现场、开放标签、整群随机、对照试验。
Lancet. 2023 Aug 19;402(10402):627-640. doi: 10.1016/S0140-6736(23)01231-X. Epub 2023 Aug 8.
5
Residual respiratory disability after successful treatment of pulmonary tuberculosis: a systematic review and meta-analysis.肺结核成功治疗后的残余呼吸功能障碍:一项系统评价和荟萃分析。
EClinicalMedicine. 2023 May 8;59:101979. doi: 10.1016/j.eclinm.2023.101979. eCollection 2023 May.
6
Lung function measurements in preclinical research: What has been done and where is it headed?临床前研究中的肺功能测量:已取得的成果及未来发展方向?
Front Physiol. 2023 Mar 22;14:1130096. doi: 10.3389/fphys.2023.1130096. eCollection 2023.
7
Advances in tuberculosis control during the past decade.过去十年结核病控制的进展。
Lancet Respir Med. 2023 Apr;11(4):311-313. doi: 10.1016/S2213-2600(23)00090-5. Epub 2023 Mar 23.
8
A mycobacterial effector promotes ferroptosis-dependent pathogenicity and dissemination.一种分枝杆菌效应蛋白促进依赖于铁死亡的致病性和传播。
Nat Commun. 2023 Mar 17;14(1):1430. doi: 10.1038/s41467-023-37148-x.
9
Spatial mapping reveals granuloma diversity and histopathological superstructure in human tuberculosis.空间图谱揭示人类结核病中的肉芽肿多样性和组织病理学超微结构。
J Exp Med. 2023 Jun 5;220(6). doi: 10.1084/jem.20221392. Epub 2023 Mar 15.
10
Adjunctive Integrated Stress Response Inhibition Accelerates Tuberculosis Clearance in Mice.辅助性整合应激反应抑制加速小鼠结核病清除。
mBio. 2023 Apr 25;14(2):e0349622. doi: 10.1128/mbio.03496-22. Epub 2023 Feb 28.